AzTrials
AzTrials

Neck Pain, PosteriorNCT05607459

Dry Needling, Manual Therapy and Exercise for Neck Pain Management

A study testing Dry Needling, Therapeutic Exercise and Manual Therapy in people with Neck Pain, Posterior, run by Camilo Jose Cela University at 1 site in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Since neck pain is the fourth highest disabling condition (with an estimated point prevalence of 20%, lifetime prevalence up to 70% and high recurrence rates), dry needling targeting myofascial trigger points in neck muscles has been proposed as an effective treatment for reducing pain and disability in patients with… Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Neck Pain, Posterior
What is being tested?
Dry Needling, Therapeutic Exercise and Manual Therapy
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
40 participants
Where
1 siteSpain
Study dates
1 Nov 2022to 30 Mar 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • To be between 18 and 65 years old
  • To have been experiencing unilateral neck pain for at least 3 months
  • To have a Neck Disability Index (NDI) score >8
  • To have a Visual Analogue Scale (VAS) score >3
  • To have at least one active MTrP located in the upper trapezius or cervical multifidus muscles

Who cannot join

  • History of whiplash injury
  • Previous cervical surgery
  • Cervical radiculopathy or myelopathy
  • Diagnosis of fibromyalgia
  • Additional analgesic treatments during the study (e.g. physiotherapy or drugs)
  • Psychiatric disorders
  • Any contraindication to the interventions proposed (e.g. fear of needles or anticoagulants)

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Juan Antonio Valera-Calero

    Alcorcón, Madrid, 28922

Other trials in Spain

About this study

Official title: Efficacy of Adding Dry Needling to a Manual Therapy and Therapeutic Exercise Interventions for Managing Neck Pain Populations: A Randomized Controlled Trial

Since neck pain is the fourth highest disabling condition (with an estimated point prevalence of 20%, lifetime prevalence up to 70% and high recurrence rates), dry needling targeting myofascial trigger points in neck muscles has been proposed as an effective treatment for reducing pain and disability in patients with chronic neck pain.

A recent meta-analysis reported whether dry needling could be recommended for this population. Low to moderate evidence suggests that dry needling can be effective at the short-term, but its effects on pressure pain sensitivity or cervical range of motion are limited.

Being tested
Dry Needling, Therapeutic Exercise, Manual Therapy, Sham Dry Needling
Keywords
Dry Needling
Medical subject headings
Neck Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Dry NeedlingOther

    Dry needling consists of a skilled intervention which uses a thin filiform needle (as those used in acupuncture) to penetrate the skin and stimulate underlying myofascial trigger points (defined as "a hyperirritable spot in skeletal muscle that is associated with a hypersensitive palpable nodule in a taut band which is painful on manual compression and can give rise to characteristic referred pain, referred tenderness, motor dysfunction and autonomic phenomena.")

    This intervention will be performed targeting the upper trapezius and cervical multifidus muscles

  • Therapeutic ExerciseBehavioural

    Patients will include a supervised therapeutic exercise program in their daily life, based on strengthening exercises for neck muscles.

  • Manual TherapyOther

    Patients will receive a manual compression (30 seconds) over myofascial trigger points located at the upper trapezius muscle, scalene muscles and cervical multifidus muscle.

  • Sham Dry NeedlingOther

    For the sham DN intervention, a similar approach will be used, but the skin will be not pierced since the material used will be a telescopic Park's sham device.

    The guide tube will be pressed against the skin mark and the sham needle will be allowed to drop. The handle will be tapped briskly, but the (blunted) needle tip will not not break the skin.

Study groups in NCT05607459
Study groupRoleWhat they receive
Dry Needling GroupExperimentalThis group will receive dry needling, manual therapy (consisting of a manual compression over myofascial trigger points located at the upper trapezius muscle, scalene muscles and cervical multifidus) and therapeutic exercise interventions
Receives: Other: Dry Needling; Behavioral: Therapeutic Exercise; Other: Manual Therapy
Sham Dry Needling GroupActive comparatorThis group will receive manual therapy (consisting of a manual compression over myofascial trigger points located at the upper trapezius muscle, scalene muscles and cervical multifidus), therapeutic exercise interventions and a previously described sham dry needling intervention.
Receives: Behavioral: Therapeutic Exercise; Other: Manual Therapy; Other: Sham Dry Needling

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Visual Analogue Scale

    A 100mm visual analogue scale will be used. The patient will indicate the level of pain intensity from 0 (no pain) to 10 (the worst pain imaginable)

    Measured: Baseline

  2. Visual Analogue Scale

    A 100mm visual analogue scale will be used. The patient will indicate the level of pain intensity from 0 (no pain) to 10 (the worst pain imaginable)

    Measured: One month follow-up

  3. Visual Analogue Scale

    A 100mm visual analogue scale will be used. The patient will indicate the level of pain intensity from 0 (no pain) to 10 (the worst pain imaginable)

    Measured: Three months follow-up

  4. Visual Analogue Scale

    A 100mm visual analogue scale will be used. The patient will indicate the level of pain intensity from 0 (no pain) to 10 (the worst pain imaginable)

    Measured: Six months follow-up

  5. Visual Analogue Scale

    A 100mm visual analogue scale will be used. The patient will indicate the level of pain intensity from 0 (no pain) to 10 (the worst pain imaginable)

    Measured: Twelve months follow-up

Secondary outcomes (20)
  1. Pittsburg Sleeping Quality Index

    This is a validated self-reported questionnaire assessing the sleeping quality. Scores range from 0 (best sleep quality) to 21 (worst sleep quality)

    Measured: Baseline

  2. Pittsburg Sleeping Quality Index

    This is a validated self-reported questionnaire assessing the sleeping quality. Scores range from 0 (best sleep quality) to 21 (worst sleep quality)

    Measured: One month follow-up

  3. Pittsburg Sleeping Quality Index

    This is a validated self-reported questionnaire assessing the sleeping quality. Scores range from 0 (best sleep quality) to 21 (worst sleep quality)

    Measured: Three months follow-up

  4. Pittsburg Sleeping Quality Index

    This is a validated self-reported questionnaire assessing the sleeping quality. Scores range from 0 (best sleep quality) to 21 (worst sleep quality)

    Measured: Six months follow-up

  5. Pittsburg Sleeping Quality Index

    This is a validated self-reported questionnaire assessing the sleeping quality. Scores range from 0 (best sleep quality) to 21 (worst sleep quality)

    Measured: Twelve months follow-up

  6. Hospital Anxiety and Depression Scale

    This is a validated self-reported questionnaire assessing the level of anxiety and depression in two subscales (HADS-A and HADS-D). Scores for each scale range from 0 to 21 points, where lower scores are associated with lower depressive and anxiety levels.

    Measured: Baseline

  7. Hospital Anxiety and Depression Scale

    This is a validated self-reported questionnaire assessing the level of anxiety and depression in two subscales (HADS-A and HADS-D). Scores for each scale range from 0 to 21 points, where lower scores are associated with lower depressive and anxiety levels.

    Measured: One month follow-up

  8. Hospital Anxiety and Depression Scale

    This is a validated self-reported questionnaire assessing the level of anxiety and depression in two subscales (HADS-A and HADS-D). Scores for each scale range from 0 to 21 points, where lower scores are associated with lower depressive and anxiety levels.

    Measured: Three months follow-up

  9. Hospital Anxiety and Depression Scale

    This is a validated self-reported questionnaire assessing the level of anxiety and depression in two subscales (HADS-A and HADS-D). Scores for each scale range from 0 to 21 points, where lower scores are associated with lower depressive and anxiety levels.

    Measured: Six months follow-up

  10. Hospital Anxiety and Depression Scale

    This is a validated self-reported questionnaire assessing the level of anxiety and depression in two subscales (HADS-A and HADS-D). Scores for each scale range from 0 to 21 points, where lower scores are associated with lower depressive and anxiety levels.

    Measured: Twelve months follow-up

  11. Neck Disability Index

    This is a validated self-reported questionnaire assessing the neck pain disability. Scores range from 0 (absence of disability) to 100 (worst disability).

    Measured: Baseline

  12. Neck Disability Index

    This is a validated self-reported questionnaire assessing the neck pain disability. Scores range from 0 (absence of disability) to 100 (worst disability).

    Measured: One month follow-up

  13. Neck Disability Index

    This is a validated self-reported questionnaire assessing the neck pain disability. Scores range from 0 (absence of disability) to 100 (worst disability).

    Measured: Three months follow-up

  14. Neck Disability Index

    This is a validated self-reported questionnaire assessing the neck pain disability. Scores range from 0 (absence of disability) to 100 (worst disability).

    Measured: Six months follow-up

  15. Neck Disability Index

    This is a validated self-reported questionnaire assessing the neck pain disability. Scores range from 0 (absence of disability) to 100 (worst disability).

    Measured: Twelve months follow-up

  16. Tampa Scale for Kinesiophobia

    The scale consist of 11 items where patients have to choose in a 4-point Likert scale how much they agree with each item, being 1 "complete disagreement" and 4 "complete agreement" (total score from 0 to 44), where higher scores indicate greater kinesiophobia.

    Measured: Baseline

  17. Tampa Scale for Kinesiophobia

    The scale consist of 11 items where patients have to choose in a 4-point Likert scale how much they agree with each item, being 1 "complete disagreement" and 4 "complete agreement" (total score from 0 to 44), where higher scores indicate greater kinesiophobia.

    Measured: One month follow-up

  18. Tampa Scale for Kinesiophobia

    The scale consist of 11 items where patients have to choose in a 4-point Likert scale how much they agree with each item, being 1 "complete disagreement" and 4 "complete agreement" (total score from 0 to 44), where higher scores indicate greater kinesiophobia.

    Measured: Three months follow-up

  19. Tampa Scale for Kinesiophobia

    The scale consist of 11 items where patients have to choose in a 4-point Likert scale how much they agree with each item, being 1 "complete disagreement" and 4 "complete agreement" (total score from 0 to 44), where higher scores indicate greater kinesiophobia.

    Measured: Six months follow-up

  20. Tampa Scale for Kinesiophobia

    The scale consist of 11 items where patients have to choose in a 4-point Likert scale how much they agree with each item, being 1 "complete disagreement" and 4 "complete agreement" (total score from 0 to 44), where higher scores indicate greater kinesiophobia.

    Measured: Twelve months follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Nov 2022
  2. Study start1 Nov 2022
  3. Primary completion28 Mar 2025
  4. Study completion30 Mar 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomized, parallel, controlled and single-blinded clinical trial
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05607459
Sponsor's protocol ID
PhD-MML
Status last verified
Jun 2025
First submitted
28 Oct 2022
Last updated
1 Jul 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Dry Needling, Therapeutic Exercise and Manual Therapy in people with Neck Pain, Posterior, run by Camilo Jose Cela University at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Visual Analogue Scale (time frame: Baseline). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in